Potassium supplementation versus bendrofluazide in mildly to moderately hypertensive Kenyans

Autor: Obel Ao, Davy K. Koech

Publikováno v: Journal of cardiovascular pharmacology. 17(3)

Eighty-four consecutive black patients who had confirmed but untreated hypertension participated in a double-blind randomized clinical trial involving potassium supplement (64 mmol/day) versus bendrofluazide (10 mg/day). Diastolic blood pressure (DBP

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::212dcaaf34da77ed3335592d42a9595a
https://pubmed.ncbi.nlm.nih.gov/1711614

Epidemiology of diabetes mellitus in a referral hospital in a tropical developing country

Autor: Obel Ao

Publikováno v: The Tohoku Journal of Experimental Medicine. 141:207-210

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d52312f8734cf246f4371e19a437a55
https://doi.org/10.1620/tjem.141.suppl_207

Effects of chlorthalidone, oxprenolol, and their combination in hypertensive blacks: a randomized double-blind crossover study

Autor: Obel Ao

Publikováno v: Journal of cardiovascular pharmacology. 13(3)

One hundred twenty black patients with mild to moderate essential hypertension participated in a double-blind placebo-controlled crossover study of the efficacy and tolerability of slow release oxprenolol versus chlorthalidone singly and in combinati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::924c645417ab103d3692a8e1623b0e33
https://pubmed.ncbi.nlm.nih.gov/2471894

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A systematic evaluation of state-of-the-art deconvolution methods in spatial transcriptomics: insights from cardiovascular disease and chronic kidney disease.

Autor: Slabowska AO; Digital Science and Innovation, Computational Biology-AI and Digital Research, Novo Nordisk A/S, Måløv, Denmark.; Department of Health Technology, Section for Bioinformatics, Technical University of Denmark, DT U, Kgs Lyngby, Denmark., Pyke C; Pathology and Imaging, Global Drug Development, Novo Nordisk A/S, Måløv, Denmark., Hvid H; Pathology and Imaging, Global Drug Development, Novo Nordisk A/S, Måløv, Denmark., Jessen LE; Department of Health Technology, Section for Bioinformatics, Technical University of Denmark, DT U, Kgs Lyngby, Denmark., Baumgart S; Digital Science and Innovation, Computational Biology-AI and Digital Research, Novo Nordisk A/S, Måløv, Denmark., Das V; Digital Science and Innovation, Computational Biology-AI and Digital Research, Novo Nordisk A/S, Måløv, Denmark.

Publikováno v: Frontiers in bioinformatics [Front Bioinform] 2024 Mar 27; Vol. 4, pp. 1352594. Date of Electronic Publication: 2024 Mar 27 (Print Publication: 2024).